Latest Research

Vascularized skin-on-chip for modeling HSV infection

Abstract

“Herpes simplex virus (HSV) naturally infects skin and mucosal surfaces, causing lifelong recurrent disease worldwide, with no cure or vaccine. Biomimetic human tissue and organ platforms provide attractive alternatives over animal models to recapitulate human diseases. Combining prevascularization and microfluidic approaches, we present a vascularized, three-dimensional skin-on-chip that mimics human skin architecture and is competent to immune-cell and drug perfusion. The endothelialized microvasculature embedded in a fibroblast-containing dermis responds to biological stimulation, while the cornified epidermis functions as a protective barrier. HSV infection of the skin-on-chip displays tissue-level key morphological and pathophysiological features typical of genital herpes infection in humans, including the production of proinflammatory cytokine IL-8, which triggers rapid neutrophil trans-endothelial extravasation and directional migration. Importantly, perfusion with the antiviral drug acyclovir inhibits HSV infection in a dose-dependent and time-sensitive manner. Thus, our vascularized skin-on-chip represents a promising platform for human HSV disease modeling and preclinical therapeutic evaluation.

ab Schematics of the major components in native human skin and skin-on-chip. c Representative 3-D reconstructed confocal image showing an overview of the cytoskeleton of the micro-engineered epidermis and dermis with underlying endothelialized microvascular network (white arrow indicates microfluidic flow direction). F-actin for cell cytoskeleton (green), DAPI for cell nucleus (blue). d Representative 3-D reconstructed confocal image illustrating basale (bottom, K14+) and corneous (upper, anucleate) layers in the epidermis of skin-on-chip. F-actin (green), K14 (red), DAPI (blue). Scale bar: 20 µm. e A cross-sectional view of hematoxylin–eosin (H&E) stained epidermis in the skin-on-chip. Scale bar: 20 µm. f Maximum intensity projected confocal image of an endothelialized microvascular network in the dermis after two weeks of culturing. F-actin (green), DAPI (blue). Scale bar: 100 µm. g Projected confocal images showing endothelium marker (CD31) expression, lumen formation (yz), and fibroblast capping of endothelial vessel (bottom). CD31 (green), Vimentin (red), DAPI (blue). Scale bar: 100 µm. h Representative fluorescence image after perfusion with 40 kDa FITC-Dextran through the microvasculature for 20 min. Graph depicts fluorescence intensity across the microvasculature inside the dashed box at 7 min (red) and 10 min after perfusion (blue). Scale bar: 100 µm. i F-actin cytoskeleton arrangement in endothelial cells and related flow shear force. Right: enlarged view within the white boxes. Scale bar: 100 µm. j Representative confocal image showing new sprouting from the main vessel lumen after angiogenetic stimuli. Right image shows cross-sectional view (yz). CD31 (green), Vimentin (red), DAPI (blue). Scale bar: 100 µm. Data are provided in a Source data file.” Reproduced under Creative Commons Attribution 4.0 International License from Sun, S., Jin, L., Zheng, Y. et al. Modeling human HSV infection via a vascularized immune-competent skin-on-chip platform. Nat Commun 13, 5481 (2022).

Figures and the abstract are reproduced from Sun, S., Jin, L., Zheng, Y. et al. Modeling human HSV infection via a vascularized immune-competent skin-on-chip platform. Nat Commun 13, 5481 (2022). https://doi.org/10.1038/s41467-022-33114-1

Read the original article: Skin-on-chip contains a stratified epidermis and dermis with a functional microvascular network

Pouriya Bayat

Published by
Pouriya Bayat

Recent Posts

Exploring Microfluidic Leukapheresis for Pediatric Leukemia

Leukapheresis is a critical treatment for children with symptomatic hyperleukocytosis, a condition where extremely high…

March 3, 2025

Understanding Microbiome Influence on Melanoma Treatment Using Microfluidics Technology

Despite the significant advancements brought by immune checkpoint inhibitors (ICIs) in melanoma treatment, patient responses…

February 18, 2025

Microfluidic Research on C. elegans for Developmental Toxicity Testing: A Novel Machine Learning Approach

Traditional developmental toxicity (DevTox) studies largely rely on mammalian models to assess chemical impacts on…

February 4, 2025

Advancing Liquid Biopsies with High-Throughput Microfluidics

Circulating tumor cells (CTCs) hold the potential for cancer diagnosis and monitoring, offering a non-invasive…

January 20, 2025

Development of a Microfluidic Impedance Flow Cytometer

Leukocyte differentiation and counting are critical for clinical diagnostics but are hindered by the low…

January 6, 2025

Enhanced Screening of Proteolytic Microorganisms Using a Passive Droplet Microfluidic Platform

Screening for microbial proteolytic activity is essential in various biotechnological applications, including bioenergy, food processing,…

December 17, 2024